These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37399858)

  • 41. Approach to the management of diabetic patients with heart failure: role of thiazolidinediones.
    Fonarow GC
    Am Heart J; 2004 Oct; 148(4):551-8. PubMed ID: 15459582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
    Handelsman Y; Anderson JE; Bakris GL; Ballantyne CM; Beckman JA; Bhatt DL; Bloomgarden ZT; Bozkurt B; Budoff MJ; Butler J; Dagogo-Jack S; de Boer IH; DeFronzo RA; Eckel RH; Einhorn D; Fonseca VA; Green JB; Grunberger G; Guerin C; Inzucchi SE; Jellinger PS; Kosiborod MN; Kushner P; Lepor N; Mende CW; Michos ED; Plutzky J; Taub PR; Umpierrez GE; Vaduganathan M; Weir MR
    J Diabetes Complications; 2022 Feb; 36(2):108101. PubMed ID: 34922811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-adherence to antidiabetic and cardiovascular drugs in type 2 diabetes mellitus and its association with renal and cardiovascular outcomes: A narrative review.
    Denicolò S; Perco P; Thöni S; Mayer G
    J Diabetes Complications; 2021 Jul; 35(7):107931. PubMed ID: 33965338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
    Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
    Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological Management of Cardiac Disease in Patients with Type 2 Diabetes: Insights into Clinical Practice.
    Patoulias D; Stavropoulos K; Imprialos K; Athyros V; Doumas M; Karagiannis A
    Curr Vasc Pharmacol; 2020; 18(2):125-138. PubMed ID: 32013815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining clinical judgment with guidelines for the management of type 2 diabetes: overall standards of comprehensive care.
    Yacoub TG
    Postgrad Med; 2014 May; 126(3):85-94. PubMed ID: 24918794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Partnering with patients to improve therapeutic outcomes: incretin-based therapy for type 2 diabetes.
    Nadeau DA
    Postgrad Med; 2010 May; 122(3):7-15. PubMed ID: 20463409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Revisiting the Diabetes-Heart Failure Connection.
    Wallner M; Eaton DM; von Lewinski D; Sourij H
    Curr Diab Rep; 2018 Oct; 18(12):134. PubMed ID: 30343339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type 2 diabetes: Why should diabetologists and cardiologists work more closely together?
    Valensi P; Picard S; Pathak A
    Diabetes Metab; 2019 Dec; 45(6):501-504. PubMed ID: 31394190
    [No Abstract]   [Full Text] [Related]  

  • 50. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
    Rees S; Williams A
    JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation and Inhibition of Sodium-Hydrogen Exchanger Is a Mechanism That Links the Pathophysiology and Treatment of Diabetes Mellitus With That of Heart Failure.
    Packer M
    Circulation; 2017 Oct; 136(16):1548-1559. PubMed ID: 29038209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
    Chiang CE; Ueng KC; Chao TH; Lin TH; Wu YJ; Wang KL; Sung SH; Yeh HI; Li YH; Liu PY; Chang KC; Shyu KG; Huang JL; Tsai CD; Hung HF; Liu ME; Chao TF; Cheng SM; Cheng HM; Chu PH; Yin WH; Wu YW; Chen WJ; Lai WT; Lin SJ; Yeh SJ; Hwang JJ
    J Chin Med Assoc; 2020 Jul; 83(7):587-621. PubMed ID: 32628427
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GLP-1 RAs in Spain: A Short Narrative Review of Their Use in Real Clinical Practice.
    Romera I; Rubio-de Santos M; Artola S; Suárez Fernández C; Conget I
    Adv Ther; 2023 Apr; 40(4):1418-1429. PubMed ID: 36821026
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concurrent diabetes and heart failure: interplay and novel therapeutic approaches.
    Karwi QG; Ho KL; Pherwani S; Ketema EB; Sun Q; Lopaschuk GD
    Cardiovasc Res; 2022 Feb; 118(3):686-715. PubMed ID: 33783483
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic implications of diabetes in cardiovascular disease.
    Cherian B; Meka N; Katragadda S; Arora R
    Am J Ther; 2009; 16(6):e51-9. PubMed ID: 19940606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Consensus document: management of heart failure in type 2 diabetes mellitus.
    Kaul U; Ray S; Prabhakar D; Kochar A; Sharma K; Hazra PK; Chandra S; Solanki DRB; Dutta AL; Kumar V; Rao MS; Oomman A; Dani S; Pinto B; Raghu TR
    Heart Fail Rev; 2021 Sep; 26(5):1037-1062. PubMed ID: 32447488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
    Sposito AC; Berwanger O; de Carvalho LSF; Saraiva JFK
    Cardiovasc Diabetol; 2018 Dec; 17(1):157. PubMed ID: 30545359
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 2.
    Arps K; Pallazola VA; Cardoso R; Meyer J; Jones R; Latina J; Gluckman TJ; Stone NJ; Blumenthal RS; McEvoy JW
    Am J Med; 2019 Jul; 132(7):e599-e609. PubMed ID: 30716297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
    Rosenberg DE; Jabbour SA; Goldstein BJ
    Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.